Shots:
- The FDA has granted 510(k) clearance to Theracor, a human umbilical cord-derived medical device offered in sheet form, for wound care
- Indicated for the same wound types as StimLabs’ Corplex P, Theracor is used for partial & full-thickness wounds, pressure, venous, diabetic, & chronic vascular ulcers, tunneled/undermined wounds, surgical sites, trauma-related injuries, & draining wounds
- Theracor is derived from human umbilical cord ECM & is intended to cover & protect wounds while maintaining a moist environment, giving clinicians an alternative to particulate products
Ref: PRnewswire | Image: StimLabs | Press Release
Related News: Bruno Vision Care Reports the US FDA Clearance of Deseyne for Presbyopia
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
